Acorah Software Products - Accounts Production 16.3.350 false true 30 April 2024 1 May 2023 false true No description of principal activity 1 May 2024 30 April 2025 30 April 2025 05426635 Mrs Linda Flanigan Dr Thomas Flanigan iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 05426635 2024-04-30 05426635 2025-04-30 05426635 2024-05-01 2025-04-30 05426635 frs-core:CurrentFinancialInstruments 2025-04-30 05426635 frs-bus:PrivateLimitedCompanyLtd 2024-05-01 2025-04-30 05426635 frs-bus:FilletedAccounts 2024-05-01 2025-04-30 05426635 frs-bus:Micro-entities 2024-05-01 2025-04-30 05426635 frs-bus:AuditExempt-NoAccountantsReport 2024-05-01 2025-04-30 05426635 frs-bus:Director1 2024-05-01 2025-04-30 05426635 frs-bus:Director2 2024-05-01 2025-04-30 05426635 2023-04-30 05426635 2024-04-30 05426635 2023-05-01 2024-04-30 05426635 frs-core:CurrentFinancialInstruments 2024-04-30
Registered number: 05426635
Oxford BioPharma Limited
Unaudited Financial Statements
For The Year Ended 30 April 2025
Oxlade Limited
Chartered Accountants
17 Saxon Square
Thame
Oxfordshire
OX9 2FS
Balance Sheet
Registered number: 05426635
2025 2024
£ £
Fixed assets 57 85
Current assets 4,999 6,845
Creditors: Amounts Falling Due Within One Year (1,217 ) (1,017 )
NET CURRENT ASSETS 3,782 5,828
TOTAL ASSETS LESS CURRENT LIABILITIES 3,839 5,913
Accruals and deferred income (839 ) (810 )
NET ASSETS 3,000 5,103
CAPITAL AND RESERVES 3,000 5,103

Notes

1. General Information
Oxford BioPharma Limited is a private company, limited by shares, incorporated in England & Wales, registered number 05426635 . The registered office is 10 Barretts Close, Stonesfield, Oxfordshire, OX29 8PW.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 2 (2024: 2)
2 2
For the year ending 30 April 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Dr Thomas Flanigan
Director
12 June 2025